A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...

The U.K. will study whether Lilly's weight loss drug can get people back to work and help tackle long-term sickness ...

New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health ...

Sir Keir Starmer and his health secretary have been lauding the potential of the new generation of weight-loss drugs. Given ...

CVS Health named David Joyner as its new chief, succeeding Karen Lynch at the helm of the struggling healthcare giant ...

Giving older Americans access to weight-loss medicines through the US Medicare program would cost $35 billion over nine years, according to a congressional analysis. Expanding coverage of weight-loss ...

Amgen has a lot riding on an experimental obesity drug that it hopes will rival those of Eli Lilly and Novo Nordisk. But one ...

Bad actors are using online ads, social media and bootleg ingredients to sell fake, inaccurate and harmful versions of these ...

Adolescents treated with GLP1R drugs for obesity exhibit fewer suicidal thoughts, indicating potential mental health benefits ...

On this week’s episode of Economic Update: how FED Chair Jerome Powell admits capitalism’s intrinsic instability, a Tennessee plastic plant won’t let workers leave before storm Helene hits, new drugs ...

Early data suggests GLP-1 drugs, renowned for their ability to assist in weight loss, may have a powerful effect on treating ...

About 40% of hormone-positive breast cancers in postmenopausal women might be linked to excess body fat, researchers reported ...